Related Experiment Video

Updated: Nov 8, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.4K

WITHDRAWN: Expression of Tmem41b and MMP13 associated with poor outcome in osteosarcomas

Guo-Hua Li1,2, Xiao Liu3, Lin-Jie Feng1

  • 1Department of Surgical Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.

Neoplasma
|April 22, 2021
PubMed

Abstract:

Ahead of Print article withdrawn by Publisher. The Publisher apologizes for any inconvenience this may cause.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.9K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.7K

Related Experiment Videos

Last Updated: Nov 8, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.4K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.9K
Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

6.7K

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K

Articles linked to this work by shared authors, journal, and citation graph.

Local anesthetic systemic toxicity with liposomal bupivacaine: a case series and literature review.

BMC anesthesiology·2026

Diet, tooth loss, and dental calculus in Guizhou adults (2024-2025).

Frontiers in public health·2026

Extracorporeal Shock Wave Therapy Combined with Subtalar Arthroereisis and Medial Column Stabilisation in the Treatment of PCFD: A Retrospective Study.

Indian journal of orthopaedics·2026

Rational design and synthesis of TBC1D2 inhibitors: Augmenting autophagy to improve sorafenib sensitivity in hepatocellular carcinoma.

European journal of medicinal chemistry·2026

Chronic intermittent hypoxia sustains the low-grade inflammatory memory of monocytes via activation of myelopoiesis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026

Effects of perinatal depression on early breastfeeding: the role of childbirth experience.

BMC pregnancy and childbirth·2026

Transcriptomic analysis of vitamin D3 (cholecalciferol)-mediated attenuation of cisplatin sensitivity in gastric cancer cells in vitro.

Neoplasma·2026

Afatinib combined with oral metronomic vinorelbine as second-line treatment for advanced lung squamous cell carcinoma: a retrospective cohort study.

Neoplasma·2026

RNA-binding protein hnRNPD promotes the proliferation of Wilms' tumor cells through activating the p38 MAPK signaling pathway.

Neoplasma·2026

CRISPR/Cas9-edited organoids as a platform for tailored research of colorectal cancer.

Neoplasma·2026

Neuroimmune treatment of advanced solid tumors: 3-year survival after angiotensin 1-7, pineal indoles, and cannabinoids.

Neoplasma·2026

SMAP1 promotes hepatoblastoma cell proliferation by modulating the C-Kit-activated ERK/MAPK pathway.

Neoplasma·2026

Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis.

Combinatorial chemistry & high throughput screening·2026

Claudin 18 is not a biomarker for breast mucinous tumor.

Journal of the Chinese Medical Association : JCMA·2026

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Journal of the National Cancer Institute·2026

Neurodevelopmental Disorder Associated with Aluminum-Adsorbed Vaccines: Reanalysis of Data from a Danish Nationwide Cohort Study.

Integrative medicine (Encinitas, Calif.)·2026

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.

EClinicalMedicine·2026

Systematic review of PET imaging features and clinical applications in pulmonary NUT carcinoma.

Frontiers in radiology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us